Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01007708 · ClinicalTrials.gov registry record · Phase 3
The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis
A Phase 3 study, sponsored by Dow Pharmaceutical Sciences.
- Completed
- Registry status
- Phase 3
- Development phase
- 780
- Enrollment target
NCT01007708: Completed Phase 3 study, sponsored by Dow Pharmaceutical Sciences.
NCT01007708 is a Phase 3 study that has completed, run by Dow Pharmaceutical Sciences. The registered enrollment target is 780 participants, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01007708, a Phase 3 study, has completed, sponsored by Dow Pharmaceutical Sciences.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 780 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of topical application of IDP-108 versus vehicle in treating patients with onychomycosis.
Interventions
- DRUG Vehicle
- DRUG IDP-108
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 780 participants |
| Start Date | 2009-11 |
| Est. Completion | 2011-12 |
| Phase | Phase 3 |
What the finished NCT01007708 record still lists
NCT01007708 is an interventional study that assigns participants to a tested intervention. The registered 780 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT01007708 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01007708 about?
NCT01007708 is a clinical study titled "The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis". The purpose of this study is to evaluate the safety and efficacy of topical application of IDP-108 versus vehicle in treating patients with onychomycosis.
What is the current status of trial NCT01007708?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 780 participants. The study started on 2009-11. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01007708?
The interventions under investigation include: Vehicle (DRUG), IDP-108 (DRUG).
Who is sponsoring clinical trial NCT01007708?
This trial is sponsored by Dow Pharmaceutical Sciences, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01007708's enrollment target sits among peer trials
780 434th of 2000 higher than 1,563 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05046613 · 780 participants
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
- NCT05100862 · 780 participants · Phase 3
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
- NCT05513872 · 780 participants · Phase 1
Overcoming Nicotine Dependence to Enable Quitting
- NCT06310031 · 780 participants · NA
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia